All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Ongoing | 2006-002081-19 | The Effects of EGFR Inhibition on Pulmonary Arterial Hypertension Associated with Systemic Sclerosis A phase II open-label safety and efficacy study. | not-yet-due | |
Ongoing | 2006-002392-40 | First international trial for diagnosia nd treatment of langerhans cell histiocytosis in adults | not-yet-due | |
Exempt | 2006-003149-17 | Phase I study of concurrent with involved-field thoracic radiotherapy for inoperable non-squamous cell lung cancer, followed by both concurrent and maintenance Bevacizumab | not-yet-due | |
Not reported | 2006-003483-59 | PRESERVE TRIAL: Pancreatic beta-cell dysfunction REStorEd by Rosiglitazone and Valsartan Effects; A 52-week randomized controlled factorial study in subjects with impaired fasting glucose and/or impai... | 2009-11-03 | due-trials |
Ongoing | 2006-006058-83 | Phase II randomized trial of combination therapy of paclitaxel and bevacizumab versus paclitaxel, capecitabine and bevacizumab as first-line treatment for locally recurrent or metastatic breast cancer... | not-yet-due | |
Exempt | 2007-001104-21 | A PHASE I/II TRIAL OF A CONDITIONALLY REPLICATION-COMPETENT ADENOVIRUS (DELTA-24-RGD) ADMINISTERED BY CONVECTION ENHANCED DELIVERY IN PATIENTS WITH RECURRENT GLIOBLASTOMA MULTIFORME | not-yet-due | |
Exempt | 2007-002962-37 | Phase I/II study of dalteparin, a low molecular weight heparin (LMWH), in combination with Sunitinib (SU11248), an oral, selective multitargeted tyrosine kinase inhibitor, as first line treatment, in ... | 2015-10-14 | not-yet-due |
Reported results | 2007-003187-22 | Clinical trials for adults HD18 for advanced stages Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma; treatment stratification by means of FDG-PET Therapi... | 2019-07-18 | due-trials |
Ongoing | 2007-004335-39 | A randomized phase II trial of docetaxel plus carboplatin versus docetaxel in hormone refractory prostate cancer patients who have progressed after response to prior docetaxel chemotherapy: RECARDO ST... | not-yet-due | |
Reported results | 2007-004474-24 | HD 16 for early stages: treatment optimization trial in the first-line treatment of early stage Hodgkin lymphoma; treatment stratification by means of FDG-PET. | 2020-12-29 | due-trials |
Ongoing | 2007-004625-14 | A phase II study of erlotinib and sorafenib in patients with locally advanced and/or metastatic (stage IIIB or IV) Non-Small cell lung cancer (NSCLC) who have not received prior chemotherapy | not-yet-due | |
Exempt | 2007-005164-27 | Botulinum toxin A intravesical injections in the treatment of Bladder Pain Syndrome/ Interstitial Cystitis | not-yet-due | |
Not reported | 2007-005306-49 | A Phase II Study Of Vorinostat (MK-0683) In Patients With Polycythaemia Vera And Essential Thrombocythaemia | 2012-08-15 | due-trials |
Reported results | 2007-005920-34 | HD17 for Intermediate Stage Hodgkin Lymphoma - Treatment Optimization Trial in the First-Line Treatment of intermediate Stage Hodgkin lymhoma; Therapy stratification by means of FDG-PET | 2020-03-21 | due-trials |
Ongoing | 2007-007075-16 | The effect of peroxisome proliferator activator receptor γ agonist pre-treatment on pegylated interferon-α2a and ribavirin efficacy in hepatitis C patients, previously resistant to treatment with pegy... | not-yet-due | |
Ongoing | 2008-005015-17 | Effect of N-acetylcysteine on thiopurine related hepatotoxicity in IBD patients | not-yet-due | |
Ongoing | 2008-005325-10 | The effect of exenatide compared to insulin glargine on cardiac function and metabolism in type 2 diabetic patients with congestive heart failure (NYHA II): a randomized-controlled trial | not-yet-due | |
Not reported | 2009-010758-36 | Pyridostigmine: using a cholinesterase inhibitor to activate the cholinergic anti-inflammatory pathway in patients with CRPS-1 | 2011-04-28 | due-trials |
Ongoing | 2009-011753-41 | Pain treatment of newborns: paracetamol rectal versus intraveneous administration, an open randomised clinical trial. | not-yet-due | |
Ongoing | 2009-012944-17 | Effect of a single dose of 14.8 MBq/kg (0.4 mCi/kg) 90Y-ibritumomab tiuxetan (“Zevalin”) following first-line R-CVP therapy in patients with follicular lymphoma on conversion rate assessed by FDG-PET ... | not-yet-due | |
Ongoing | 2009-013403-55 | Early recognition and optimal treatment of delirium in patients with advanced cancer. | not-yet-due | |
Ongoing | 2009-014272-21 | Effect of additional treatment with exenatide in patients with an acute myocardial infarction: the EXAMI trial) | not-yet-due | |
Not reported Terminated | 2009-016080-11 | A COMPREHENSIVE AND TARGETED THERAPY APPROACH IN PEDIATRIC MALIGNANT PONTINE GLIOMAS | 2018-06-01 | due-trials |
Exempt Terminated | 2010-018327-26 | Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer. | not-yet-due | |
Ongoing | 2010-019252-41 | DALI dosing study of Vitamin D in obese pregnant women | not-yet-due | |
Ongoing | 2010-019891-54 | Effects of oral corticosteroids and DMSO on inflammatory signs and symptoms in Complex Regional Pain Syndrome type 1 | not-yet-due | |
Ongoing | 2010-019982-27 | Targeted therapy selection based on tumor tissue kinase activity profiles for patients with advanced solid malignancies, an exploratory study | not-yet-due | |
Ongoing | 2010-020397-42 | The efficacy of an antigenic marker lesion for the therapeutic effect in patients with multiple, Ta/T1, G1/G2, non-muscle invasive bladder cancer (NMIBC) treated with TUR followed by IL-2 instillation | not-yet-due | |
Ongoing | 2010-020424-21 | Betablocker Therapy in Pulmonary Arterial Hypertension | not-yet-due | |
Completed, but no date Terminated | 2010-021797-10 | A phase II randomized multicenter study on efficacy and safety of cultured autologous skin (Tiscover®) and acellular dermal matrix (AS210) in chronic (arterio-)venous ulcers | bad-data | |
Completed, but no date | 2010-021943-41 | Treatment optimization of cetuximab in patients with metastatic colorectal cancer based on tumour uptake of 89Zr-labeled cetuximab assessed by PET | bad-data | |
Ongoing | 2010-023233-30 | ‘Intravenous iron treatment in iron deficient patients with pulmonary arterial hypertension' | not-yet-due | |
Exempt | 2010-023577-20 | Revlimid, Endoxan, Prednisone Evaluation After prior revlimid Treatment (REPEAT): A phase 1 and phase 2 study of lenalidomide (Revlimid) in combination with cyclophosphamide (endoxan) and prednisone (... | not-yet-due | |
Exempt Terminated | 2010-024515-13 | Phase 1-2 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer. | not-yet-due | |
Listed as ongoing, but also has a completion date | 2011-000440-22 | MULTICENTER TRIAL ESTIMATING THE PERSISTANCE OF MOLECULAR REMISSION IN CHRONIC MYELOID LEUKAEMIA AFTER STOPPING TKI | 2017-11-20 | bad-data |
Ongoing | 2011-000538-12 | An exploratory open-label PET-observer-blinded pilot study to evaluate the effect of 3 and 12 months treatment with Aliskeren-based versus amlodipin-based antihypertensive treatment in patients with a... | not-yet-due | |
Ongoing | 2011-000753-24 | Central effects of endogenous GLP-1 and the GLP-1 analog liraglutide on brain satiety and reward circuits and feeding behavior in diabetes. | not-yet-due | |
Ongoing | 2011-001251-37 | Exploring alternative wound care treatment for percutanous gastrostomy site infection: a prospective, randomized, open, blinded end-point (PROBE) design. | not-yet-due | |
Not reported | 2011-002211-28 | Perioperative selective decontamination of the digestive tract (SDD) in elective colorectal cancer patients: a multicenter randomized clinical trial | 2020-03-25 | due-trials |
Ongoing | 2011-003325-10 | A randomized controlled trail on the effects of periconceptional and prenatal folic acid supplementation on congenital anomalies and preterm birth | not-yet-due | |
Ongoing | 2011-003570-89 | The effect of interferon beta-1a treatment on functional adaptation in Multiple Sclerosis (MS) Het effect van interferon beta-1a behandeling op functionele adaptatie in Muliple Sclerose (MS | not-yet-due | |
Completed, but no date Terminated | 2011-004446-17 | Metoclopramide, dexamethasone or Aloxi for the prevention of delayed chemotherapy-induced nausea and vomiting in moderately emetogenic non-AC-based chemotherapy: the MEDEA trial | bad-data | |
Completed, but no date, and reported results | 2011-004495-12 | Antibiotic treatment alone for children with acute appendicitis; a prospective cohort study part of the Antibiotic versus Primary Appendectomy for Children with acute appendicitis; the APAC trial. | bad-data | |
Ongoing | 2011-004683-30 | A phase II study of sorafenib and metformin in patients with locally advanced and/or metastatic non-smal cell lung cancer (NSCLC) with a K-Ras mutation | not-yet-due | |
Completed, but no date | 2011-004762-15 | Early pharmacological intervention to prevent delirium: HAlopeRidol PrOphylaxis in Older emergency department patieNts. The HARPOON study Preventie van delirium door vroegtijdige pharmacologische i... | bad-data | |
Ongoing | 2011-005003-32 | A randomized multicenter clinical trial for patients with multi-organ, colorectal cancer metastases comparing the combination of chemotherapy and maximal tumor debulking versus chemotherapy alone. | not-yet-due | |
Ongoing | 2011-005160-23 | Hismys study. Misoprostol for cervical priming prior to hysteroscopy in postmenopausal and nulliparous premenopausal women; a multi-centre randomised placebo controlled trial | not-yet-due | |
Ongoing | 2011-005165-21 | De-ESCALaTE HPV: Determination of Epidermal growth factor receptor-inhibitor (cetuximab) versus Standard Chemotherapy (cisplatin) early And Late Toxicity Events in Human Papillomavirus-positive oropha... | not-yet-due | |
Ongoing | 2011-006009-85 | Prediction of response to kinase inhibitors based on protein phosphorylation profiles in tumor tissue from advanced renal cell cancer patients | not-yet-due | |
Ongoing | 2012-000345-12 | A phase II study of gefitinib and fulvestrant in patients with advanced, EGFR mutated non-small cell lung cancer pretreated with reversible EGFR tyrosine kinase inhibitors Een Fase II studie van ge... | not-yet-due | |
Ongoing | 2012-000850-75 | Clinical evaluation of the efficacy of methylnaltrexone in resolving constipation induced by different opioid subtypes combined with laboratory analysis of immunomodulatory and antiangiogenic effects ... | not-yet-due | |
Completed, but no date Terminated | 2012-001530-34 | Varenicline, a partial nicotinic receptor agonist for the treatment of Excessive Daytime Sleepiness in Parkinson’s Disease: a placebo-controlled cross-over study | bad-data | |
Ongoing | 2012-001541-40 | Effect of Carbon Dioxide Enriched Ambient Air on Pharmacokinetics and Deposition In Bronchiectasis Patients Using Tobramycin Inhalation: A proof of concept study. Het effect van koolstofdioxide ve... | not-yet-due | |
Ongoing | 2012-001597-29 | Tumor uptake of 89Zirconium-ofatumumab and 89Zirconium-rituximab in diffuse large B cell lymphoma patients Tumor opname van 89Zirconium-ofatumumab en 89Zirconium-rituximab bij patienten met een dif... | not-yet-due | |
Not reported Terminated | 2012-001599-12 | The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients | 2022-05-16 | due-trials |
Completed, but no date | 2012-002303-18 | The Dutch Flutemetamol in Young Dementia Study De Nederlandse Flutemetamol in Vroege Dementie Study | bad-data | |
Not reported Terminated | 2012-002891-15 | Phase II study of sunitinib rechallenge in patients with metastatic renal cell carcinoma. | 2017-04-20 | due-trials |
Ongoing | 2012-003141-16 | Efficacy and feasibility of first-line treatment with risk-adapted dose-adjusted EPOCH-R (DA-EPOCH-R) in patients with Burkitt lymphoma. A phase II clinical trial. | not-yet-due | |
Ongoing | 2012-003359-12 | The effect of a high and low protamine-to-heparin dosing on perioperative hemostasis: a randomized clinical trial. Het effect van een hoge en lage protamine:heparine doseringsratio op perioperatie... | not-yet-due | |
Ongoing | 2012-003616-31 | Uptake and biodistribution of 89Zirconium-labeled ipilimumab in ipilimumab treated patients with metastatic melanoma Opname en biodistributie van 89Zirconium-gelabeld ipilimumab in patienten met ge... | not-yet-due | |
Completed, but no date, and reported results | 2012-003981-42 | Estrogen receptor and androgen receptor imaging in metastatic breast cancer patients | bad-data | |
Ongoing | 2012-004321-25 | A phase II, single arm, multicenter study of nilotinib in combination with pegylated interferon α2b in patients with suboptimal molecular response or stable detectable molecular residual disease after... | not-yet-due | |
Ongoing | 2012-004961-42 | Measurement of tumor kinase inhibitor concentrations using PET imaging in patients with advanced solid malignancies Het meten van concentraties kinaseremmer in tumorlesies bij patienten met vergevo... | not-yet-due | |
Ongoing | 2012-005066-36 | Effect of Growth Hormone replacement therapy on cardiovascular risk factors in adult patients with severe growth hormone deficiency: association with IGF-I concentration | not-yet-due | |
Completed, but no date, and reported results | 2012-005332-29 | Prevention of depression and poor physical function in older persons with vitamin D supplementation Preventie van depressie en matig lichamelijk functioneren bij ouderen met vitamine D-suppletie | bad-data | |
Ongoing | 2013-000238-37 | Treatment guided by detection of Minimal Residual Disease after allogeneic stem cell transplantation in Acute Myeloid Leukaemia | not-yet-due | |
Reported results | 2013-000789-13 | DALI: Vitamin D And Lifestyle Intervention for Gestational Diabetes Mellitus (GDM) Prevention - A European multicentre, randomised trial | 2016-01-31 | due-trials |
Not reported Terminated | 2013-001722-25 | Cholinesterase inhibitors to slow progression of visual hallucinations in Parkinson’s disease: a multi-center placebo-controlled trial (CHEVAL) | 2018-09-27 | due-trials |
Ongoing | 2013-001743-31 | The cardiovascular effects of hyperoxia during and shortly after CABG surgery | not-yet-due | |
Not reported Terminated | 2013-002023-41 | Image guided treatment optimalization with cetuximab for patients with metastatic colorectal cancer: IMPACT - CRC Optimalisatie van de behandeling van uitgezaaide dikke darmkanker met cetuximab mid... | 2021-01-07 | due-trials |
Ongoing | 2013-002563-25 | Pilot study to determine the effect of fractionated radiotherapy on expression of pro-angiogenic factors in oeshophagus carcinoma Een pilot studie om het effect te onderzoeken van gefractioneerde r... | not-yet-due | |
Exempt, with results Terminated | 2013-002663-25 | A phase I- IIa open-label clinical trial, evaluating the therapeutic vaccine hVEGF26-104/RFASE in patients with advanced solid tumors Een fase I-IIa klinische studie naar het therapeutisch vaccin h... | not-yet-due | |
Not reported Terminated | 2013-002670-40 | Noninvasive Imaging of Vulnerable Inflammatory Coronary Plaque using Cardiac PET/CT in Humans: a feasibility study Onderzoek naar het gebruik van verschillende PET-tracers voor het vaststellen van ... | 2018-11-15 | due-trials |
Ongoing | 2013-003354-24 | Influence of exogenous growth hormone administration on circulating levels of Klotho in healthy and CKD subjects | not-yet-due | |
Not reported | 2013-003658-26 | Treat-to-target strategy for early RA patients in usual clinical practice: The COBRA Cohort Study | 2018-12-18 | due-trials |
Ongoing | 2013-003733-15 | The Dutch CSF and PET Biomarker Concordance of Alzheimer’s Disease pathology study De Nederlandse CSF en PET Biomarker Concordantie van Alzheimer pathologie studie | not-yet-due | |
Reported results | 2013-003949-41 | Role of different phosphate binders on absorption of vitamin K, metabolism of matrix γ-carboxy-glutamaat (Gla) proteïne (MGP). Rol van verschillende fosfaatbinders t.a.v. absorptie van vitamine K, ... | 2018-10-01 | due-trials |
Ongoing | 2013-004120-11 | PI3K pathway analysis in tumor tissue and circulating DNA to obtain further insight in the efficacy of everolimus when combined with exemestane. A side-study protocol attached to standard treatment wi... | not-yet-due | |
Reported results | 2013-004635-69 | A phase II study of obinutuzumab monotherapy in rituximab-refractory follicular lymphoma Obinutuzumab monotherapie voor rituximab-refractair folliculair lymfoom | 2019-10-25 | due-trials |
Ongoing | 2014-000047-33 | The effect of high-resistance muscle strength training and vitamin D supplementation in persons with knee osteoarthritis Het effect van hoog-intensieve spierkrachttraining en vitamine D suppletie b... | not-yet-due | |
Ongoing | 2014-000219-15 | Amyloid pathology in cognitively normal elderly subjects Amyloid pathologie in cognitief normale ouderen | not-yet-due | |
Ongoing | 2014-000304-96 | Sentinel lymph node identification in colon cancer using a radioactive and fluorescent tracer | not-yet-due | |
Ongoing | 2014-000562-21 | Amyloid-PET as a diagnostic marker in daily practice. Amyloid-PET als een diagnostische marker in de dagelijkse praktijk. | not-yet-due | |
Ongoing | 2014-001012-19 | Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis Het effect van fingolimod op functionele breinadaptatie en klinische maten in multiple sclerose | not-yet-due | |
Not reported | 2014-001546-25 | Short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with Fever of Unknown Origin: a randomized multicenter open-label non-inferiority ... | 2019-08-05 | due-trials |
Listed as ongoing, but also has a completion date and reported results | 2014-001561-27 | Vincristine-induced peripheral neuropathy in children with acute lymphoblastic leukemia: comparing one-hour infusions with bolus injections (the VINCA-study) Vincristine-geïnduceerde perifere neuro... | 2022-02-01 | bad-data |
Reported results | 2014-002178-35 | A phase 4, monocenter, randomized, open label, comparator-controlled, parallel-group, mechanistic intervention trial to assess the effect of 8-week treatment with the glucagon-like peptide-1 receptor ... | 2019-08-14 | due-trials |
Ongoing | 2014-002514-23 | Reduction Of Microvascular Injury Utilizing Sonolysis | not-yet-due | |
Not reported | 2014-002547-17 | Grey matter microglial imaging with [18F]DPA-714 in progressive MS patients Beeldvorming van microglia in de grijze stof met [18F]DPA-714 bij progressieve MS patiënten | 2016-01-21 | due-trials |
Completed, but no date, and reported results | 2014-002832-15 | Ulipristal versus Gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy: a double blind randomized controlled trial Ulipristal versus Gonadotropine-releasing hormoon agonists voo... | bad-data | |
Ongoing | 2014-002928-27 | Observing Platelet Activability in a Once daily vs. a More frequent Aspirin intake regimen | not-yet-due | |
Ongoing | 2014-003385-24 | The Recall-study: Rivastigmine for ECT-induced Cognitive Adverse effects in Late Life Depression: a multicenter, randomized, double-blind, placebo-controlled, crossover trial De Recall studie: Riv... | not-yet-due | |
Ongoing | 2014-003468-19 | The effects of hyperoxia on organ dysfunction and outcome in critically ill patients with SIRS Het effect van hyperoxie op orgaan dysfunctie en overleving in Intensive Care patienten met SIRS | not-yet-due | |
Ongoing | 2014-003469-10 | The application of contrast-enhanced ultrasound to facilitate thrombolysis in patients with acute peripheral arterial occlusions. | not-yet-due | |
Ongoing | 2014-003680-38 | Pharmacokinetics of two different high dose regimes of intravenous vitamin C in critically ill patients Farmacokinetiek van twee verschillende hoge doseerregimes van intraveneus vitamine C bij IC p... | not-yet-due | |
Completed, but no date | 2014-003932-38 | Advanced imaging in laparoscopic HIPEC for peritoneal carcinomatosis of colorectal orgin to improve cytoreduction; a feasibility study | bad-data | |
Ongoing | 2014-004739-38 | Follow-up of the FRUIT-RCT; aspirin resistance and cardiovascular risk factors in women after recurrent hypertensive disorders in pregnancy | not-yet-due | |
Listed as ongoing, but also has a completion date | 2014-005363-33 | Reducing Micro Vascular dysfunction In revascularized STEMI patients by off-target properties of ticagrelor | 2019-04-09 | bad-data |
Ongoing | 2015-000644-42 | Laparoscopic advanced Imaging Techniques in Endometriosis therapy: LITE-study. A pilot trial. | not-yet-due | |
Reported results | 2015-002729-21 | The Glucocorticoid Low-dose Outcome in RheumatoId Arthritis Study Comparing the cost-effectiveness and safety of additional low-dose glucocorticoid in treatment strategies for elderly patients with rh... | 2021-01-29 | due-trials |
Not reported | 2015-003220-31 | Low dose aspirin in the Prevention of Recurrent Spontaneous Preterm Labour – the APRIL study | 2020-03-27 | due-trials |
Exempt Terminated | 2015-003554-41 | A phase I/II “minor histocompatibility antigen UTA2-1 loaded, PD-L silenced Dendritic cell vaccination trial after allogeneic Stem Cell Transplantation to improve the safety and efficacy of Donor Lym... | not-yet-due | |
Ongoing | 2015-003705-42 | Longitudinal imaging of tau accumulation in the preclinical stages of AD Longitudinale beeldvorming van de accumulatie van tau in de preklinische stadia van de ziekte van Alzheimer | not-yet-due | |
Ongoing | 2015-003818-24 | A phase 4, monocenter, randomized, double-blind, comparator-controlled, parallel-group, mechanistic intervention trial to assess the effect of 12-week treatment with the sodium-glucose linked transpor... | not-yet-due | |
Exempt | 2015-003862-10 | A phase 1 and phase 2 study of daratumumab in combination with all-trans retinoic acid in relapsed/refractory multiple myeloma | 2022-10-18 | not-yet-due |
Reported results | 2015-004230-10 | Validating in vivo quantification of tau with [18F]AV-1451 PET Het valideren van in vivo quantificatie van tau met [18F]AV-1451 PET | 2018-11-08 | due-trials |
Ongoing | 2015-004260-10 | 89Zirconium-labeled pembrolizumab as predictive imaging biomarker of response and toxicity in pembrolizumab treated patients with non-small-cell lung cancer – a feasibility study 89Zirconium gelabe... | not-yet-due | |
Ongoing | 2015-004760-11 | 89Zirconium-labeled nivolumab and 18F-labeled anti-PD-L1 as predictive imaging biomarkers of response and toxicity in nivolumab treated patients with non-small-cell lung cancer – a feasibility study ... | not-yet-due | |
Reported results | 2015-004937-29 | Towards early identification of response to CABAZItaxel in patients with metastatic castration-resistant prostate cancer: potential of 18F-Choline PET-CT (CABAZIPET). Vroegtijdig identificeren va... | 2019-05-01 | due-trials |
Ongoing | 2015-004998-33 | Multicenter prospective trial after first or second unsuccessful treatment discontinuation in chronic myeloid leukemia estimating the efficacy of nilotinib in inducing the persistence of molecular rem... | not-yet-due | |
Ongoing | 2015-005765-23 | Companion biomarker development for MEDI4736 treated non-small-cell lung cancer patients using 89Zirconium-labeled MEDI4736 – a feasibility study Biomarker ontwikkeling voor MEDI4736 in de behandel... | not-yet-due | |
Completed, report not yet due | 2015-005811-34 | Pregnancy reLated Acute hyperTension INtervention Action: a randomized trial comparing labetalol and nicardipine in women with acute hypertension in pregnancy (Platina-trial) | 2023-08-31 | not-yet-due |
Ongoing | 2016-000345-31 | Towards personalized dosing of natalizumab in multiple sclerosis Op weg naar een gepersonaliseerde behandeling met natalizumab in multiple sclerose | not-yet-due | |
Ongoing | 2016-001353-41 | Oxygenation of Affected Limbs in CRPS-I Patients | not-yet-due | |
Completed, report not yet due Terminated | 2016-001797-15 | A phase II/III study of high-dose, intermittent sunitinib in patients with recurrent glioblastoma multiforme Een fase II/III studie met intermitterend, hoge dosis sunitinib bij patiënten met een re... | 2023-01-31 | not-yet-due |
Completed, but no date | 2016-002342-23 | The cardiovascular dose-response to supplemental oxygen in healthy volunteers | bad-data | |
Not reported Terminated | 2016-002635-15 | Study to Identify Factors associated with Resilience to Clinical Dementia at Old Age Studie naar de beschermende factoren voor dementie bij mensen boven de 90 jaar | 2018-10-02 | due-trials |
Not reported Terminated | 2016-003819-36 | Combining SBRT and pembrolizumab in early stage non-small cellular lungcancer patients planned for surgery: exploring safety and immunological proof of principle. De combinatie van stereotactische... | 2022-03-11 | due-trials |
Not reported Terminated | 2016-004303-32 | ASsesment of Platelet function and Inhibition in patients Recovering from severe INfection | 2021-03-18 | due-trials |
Ongoing | 2016-004545-91 | Continuous use of Oral contraceptives as an alternative for long term Pituitary down-regulation with GnRH agonist prior to IVF/ICSI in Endometriosis patients: a randomised controlled trial (COPIE tria... | not-yet-due | |
Reported results Terminated | 2017-000137-31 | Pulmonary Hypertension REversal in Clusters of Patients With Identical Pathobiological Substrates. 6-Mercaptopurine Proof-of-Concept Trial | 2019-07-01 | due-trials |
Completed, report not yet due Terminated | 2017-000169-60 | A phase 2 study of nivolumab combined with daratumumab with or without low dose cyclophosphamide in relapsed/refractory multiple myeloma | 2023-01-25 | not-yet-due |
Completed, report not yet due Terminated | 2017-000364-15 | A randomized phase II/III study of pulsatile high-dose sunitinib versus TAS-102 in patients with metastatic colorectal carcinoma (mCRC). Gerandomiseerde fase II-III studie tussen sunitinib versus T... | 2023-01-24 | not-yet-due |
Ongoing | 2017-000841-28 | Combined effects of SGLT2 inhibition and GLP-1 receptor agonism on food intake, body weight and central satiety and reward circuits in obese T2DM patients | not-yet-due | |
Ongoing | 2017-001438-25 | A Study to Explore the Safety, Tolerability, Pharmacokinetic Profile, and Potential Efficacy of Guanabenz in Patients With Early Childhood Onset Vanishing White Matter (VWM) | not-yet-due | |
Not reported | 2017-001547-12 | A phase 4, monocenter, randomized, double-blind, comparator-controlled, 3-armed parallel mechanistic intervention trial to assess the effect of 8-week empagliflozin (SGLT-2 inhibitor) monotherapy, fol... | 2021-07-01 | due-trials |
Ongoing | 2017-001840-37 | ERtugliflozin triAl in DIabetes with preserved or reduced ejeCtion FrAcTion mEchanistic evaluation in Heart Failure: "ERADICATE-HF" | not-yet-due | |
Ongoing | 2017-002022-20 | The effect of inspiratory oxygen fraction on the ratio of partial arterial oxygen pressure and inspiratory oxygen fraction (PaO2/FiO2 ratio) in mechanically ventilated patients with and without mild t... | not-yet-due | |
Ongoing | 2017-002478-37 | Right Dose, Right Now: Randomized Clinical Trial Meteen de juiste dosis: gerandomiseerde klinische trial | not-yet-due | |
Ongoing | 2017-002636-16 | Cognitive impairment and functional reorganization in multiple sclerosis: The role of GABA and glutamate Cognitieve achteruitgang en functionele reorganisatie in multiple sclerose: de rol van GABA ... | not-yet-due | |
Not reported | 2017-003072-31 | The effects of sex hormone administration on marrow and visceral adiposity | 2021-12-17 | due-trials |
Not reported Terminated | 2017-003766-27 | The DREAMING study: Efficacy of low dose amitriptyline and mirtazapine for insomnia disorder: a double-blind, randomized, placebo-controlled trial in general practice | 2022-06-28 | due-trials |
Exempt Terminated | 2017-003860-11 | 11C-erlotinib brain uptake in Diffuse Intrinsic Pontine Glioma imaged by PET | 2018-06-01 | not-yet-due |
Ongoing | 2017-004318-25 | Early high-dose vitamin C in post-cardiac arrest syndrome. Vroege hoge dosis intraveneuze vitamine C na reanimatie. | not-yet-due | |
Not reported Terminated | 2017-004737-85 | Alkaline Phosphatase to prevent ischemia reperfusion injury in living kidney transplantation | 2020-09-10 | due-trials |
Ongoing | 2017-004850-40 | [18F]Fluoride PET-CT imaging for detection and monitoring of bone formation in spondyloarthritis [18F]Fluoride PET-CT beeldvorming voor het aantonen en monitoren van botformatie bij spondylartriti... | not-yet-due | |
Ongoing | 2017-005120-16 | Ulipristal versus standard surgical treatment in symptomatic uterine fibroids Ulipristal versus standaard chirurgie in de behandeling van symptomatische uterine myomen | not-yet-due | |
Completed, but no date | 2018-000029-29 | Extra energy for hearts with a genetic defect: ENERGY trial Extra energie voor harten met een genetische afwijking: ENERGY trial | bad-data | |
Ongoing | 2018-000748-24 | Partial neuromuscular blockade to facilitate lung and diaphragm protective mechanical ventilation in ICU patients. A randomized controlled pilot study. | not-yet-due | |
Ongoing | 2018-001114-15 | Positron emission tomography with macrophage targeting to select individuals at risk for rheumatoid arthritis. Positron emissie tomografie met een macrofagen tracer voor het selecteren van individ... | not-yet-due | |
Ongoing | 2018-001277-24 | Microvascular Recovery in Acute MI, a single center, prospective, randomized, single blind parallel-group comparison of sonothrombolysis versus standard of care performed after (post) coronary reperfu... | not-yet-due | |
Ongoing | 2018-001678-10 | Tofacitinib: salvage therapy for patients with RCDII - a pilot study Tofacitinib: laatste redmiddel voor patiënten met RCDII - een pilot study | not-yet-due | |
Completed, report not yet due | 2018-002013-35 | FES (16α-[18F]-fluoro-17β-estradiol)-PET: Towards a new standard to stage clinical stage II/III and recurrent, estrogen receptor positive (ER+) breast cancer? Pilot study to compare [18F]FES-PET and [... | 2023-01-29 | not-yet-due |
Reported results | 2018-002170-52 | TrimetaziDine as a Performance-enhancING drug in Heart Failure with Preserved Ejection Fraction | 2021-11-22 | due-trials |
Listed as ongoing, but also has a completion date | 2018-002277-22 | AMYPAD Prognostic and Natural History Study (PNHS), an open label, prospective, multicentre, cohort study in individuals without dementia to evaluate the additional value of quantitative amyloid imagi... | 2022-07-06 | bad-data |
Not reported | 2018-002643-28 | Safety and tolerability of neoadjuvant nivolumab for locally advanced resectable oral cancer, combined with [18F]BMS-986192 / [18F]-FDG PET imaging and immunomonitoring for response prediction. Ve... | 2022-01-06 | due-trials |
Exempt | 2018-002752-33 | A phase I/II trial towards the safety and efficacy of preemptive vaccination with PD-L silenced, minor histocompatibility antigen UTA2-1 peptide-loaded Dendritic Cells after Allogeneic Stem Cell Trans... | not-yet-due | |
Ongoing | 2018-004153-24 | Tubal flushing with oil-based contrast during HSG in subfertile women: Is early flushing effective and cost-effective as compared to delayed flushing? Is het verrichten van een HSG met olie contras... | not-yet-due | |
Ongoing | 2018-004192-12 | Oil- based versus water-based contrast media for hysterosalpingography (HSG) in infertile women with unevaluated indications: a randomized controlled trial | not-yet-due | |
Ongoing | 2018-004429-94 | [18F]PEG-folate PET-CT imaging for monitoring of therapy response in rheumatoid arthritis patients [18F]PEG-folaat PET-CT beeldvorming voor de monitoring van response op therapie bij reumatoïde art... | not-yet-due | |
Ongoing | 2018-004466-34 | Tau PET imaging in cognitively normal elderly subjects: A twin approach Tau PET-beeldvorming bij cognitief normale oudere proefpersonen: een tweeling benadering | not-yet-due | |
Completed, but no date | 2019-000730-19 | A phase 4, monocenter, prospective, randomized, placebo-controlled, double-blind, cross-over mechanistic intervention trial to assess effect of 4-week Ertugliflozin (SGLT-2 inhibitor) therapy on renal... | bad-data | |
Ongoing | 2019-001306-23 | Reversal Of Arterial Disease by modulating Magnesium and Phosphate | not-yet-due | |
Not reported Terminated | 2019-001518-40 | Netherlands study of Optimal, PERsonalized Antidepressant use (OPERA-DISCONTINUATION) Nederlandse studie naar Optimaal gePERsonaliseerd Antidepressiva gebruik (OPERA-AFBOUW) | 2022-08-12 | due-trials |
Ongoing | 2019-001883-31 | Microvascular Recovery using contrast Ultrasound in ST-elevation Myocardial Infarction in the ambulance (MRUSMI-Ambulance) | not-yet-due | |
Ongoing | 2019-003127-38 | Efficacy of add-on high dose simvastatin on markers for disease progression in MS patients treated with ocrelizumab and natalizumab (SIMSON), a phase II clinical trial. Effectiviteit van add-on hog... | not-yet-due | |
Completed, but no date | 2019-003141-15 | A phase 4, monocenter, randomized, double-blind, placebo-controlled, 4-armed cross-over mechanistic intervention study to assess the renal hemodynamic effect of mono- and combination therapy with empa... | bad-data | |
Ongoing | 2019-003324-20 | Saracatinib trial TO Prevent FOP Een onderzoek ter beoordeling van de veiligheid, verdraagbaarheid en effecten op abnormale botvorming van het onderzoeksgeneesmiddel AZD0530 (saracatinib) bij patië... | not-yet-due | |
Ongoing | 2019-003454-83 | Ipilimumab plus Nivolumab and ChemoRadiotherapy followed by Surgery in patients with resectable and borderline resectable T3-4N0-1 NSCLC | not-yet-due | |
Ongoing | 2019-003601-10 | Treatment of Skin Severity in Ichthyosis with Hyperbaric Oxygen Therapy | not-yet-due | |
Ongoing | 2019-003698-24 | Patient preference-based phosphate binder therapy in haemodialysis patients: a feasibility study on patient satisfaction Haalbaarheid van een behandelstrategie gebaseerd op voorkeuren van de patien... | not-yet-due | |
Ongoing | 2019-003740-77 | Personalized prediction and regulation of 5-FU exposure Gepersonaliseerd voorspelling en regulatie van 5-FU blootstelling | not-yet-due | |
Completed, but no date | 2019-004284-51 | An exploratory study of durvalumab (MEDI4736) uptake during concurrent chemoradiotherapy in stage III NSCLC patients using 89Zr-labeled durvalumab PET | bad-data | |
Ongoing | 2019-004604-35 | A phase 2 study of CC220 (iberdomide) combined with low-dose cyclophosphamide and dexamethasone in relapsed/refractory multiple myeloma (IberCd): ICON study Een fase 2 studie van iberdomide gecom... | not-yet-due | |
Ongoing | 2020-000165-16 | A single-center, prospective, placebo-controlled, double-blind, randomized, cross-over mechanistic intervention study to investigate the effect of empagliflozin on kidney function in people with eithe... | not-yet-due | |
Completed, but no date | 2020-001097-29 | Rescue by radiotherapy and anti-CTLA4/PD-1 after failure of anti-PD-1 therapy in metastatic NSCLC patients, a proof-of-concept study. | bad-data | |
Ongoing | 2020-001952-16 | Progesterone for Breast Development in Trans Women; Assessment of effects and safety -a pilot trial- | not-yet-due | |
Ongoing | 2020-002079-36 | TGF-β And PDL-1 inhibition with Bintrafusp alfa in Esophageal Squamous Cell carcinoma combined with chemoradiation TheRapY (TAPESTRY) TGF-β en PDL-1 blokkade met Bintrafusp alfa in plaveiselcelcarc... | not-yet-due | |
Ongoing | 2020-002185-14 | 18F-Prostate Specific Membrane Antigen PET-CT as a potential novel imaging modality for pancreatic cancer: A pilot study | not-yet-due | |
Ongoing | 2020-002196-35 | post-trial access cohort BUmetanide for Developmental DIsorders Post trial access Bumetanide voor ontwikkelingsstoornissen | not-yet-due | |
Ongoing | 2020-002909-25 | Blood-borne assessment of stromal activation in esophageal adenocarcinoma to guide tocilizumab therapy: a randomized phase II proof-of-concept study Behandeling van patiënten met resectabel oesofag... | not-yet-due | |
Ongoing | 2020-003025-37 | COMBINING AFATINIB AND CONCURRENT CHEMOTHERAPY, FOLLOWED BY OSIMERTINIB AND CONCURRENT CHEMOTHERAPY, IN UNTREATED EGFR POSITIVE NSCLC TUMORS | not-yet-due | |
Ongoing | 2020-003385-40 | REStoring mood after Early life Trauma – Glucocorticoid Receptor (GR) blockade as disease-modifying treatment for depression with childhood trauma Herstel van stemming na jeugdtrauma - Glucocortico... | not-yet-due | |
Ongoing | 2020-004294-48 | Glioma: Reducing Anxiety by conSuming cannabinoidS – GRASS study. Treating anxiety with CBD in glioma patients – A randomized-controlled trial GRIP op spanning, bezorgdheid en piekeren, de GRASS st... | not-yet-due | |
Ongoing | 2020-004413-13 | Dual-immunotherapy and short-course medium-dose radiotherapy, followed by surgery for tumor microenvironment modification in early stage NSCLC | not-yet-due | |
Reported results Terminated | 2020-005447-23 | A randomised, double-blind, placebo-controlled study to investigate the safety and efficacy of intravenous imatinib mesilate (Impentri®) in subjects with Acute Respiratory Distress Syndrome induced by... | 2022-03-21 | due-trials |
Ongoing | 2021-000070-29 | A Proof-of-Concept Study to Explore the Potential Efficacy of Deferiprone in Patients With Pelizaeus-Merzbacher disease (PMD) | not-yet-due | |
Ongoing | 2021-000610-42 | Dynamic and test-retest whole body [18F]FES PET imaging in patients with metastatic ER+ breast cancer. | not-yet-due | |
Ongoing | 2021-000781-15 | Neuroinflammation and post-infectious fatigue in individuals with and without Covid-19 Chronische vermoeidheidsklachten en neuro-inflammatie na een covid-19 infectie | not-yet-due | |
Not reported | 2021-001072-41 | COBRA-KAI study: COVID-19 vaccination in patients with reduced B-cell and T-cell immunity: response after vaccination of a kaleidoscopic group hematological patients, what’s the impact? COBRA-KAI s... | 2022-07-07 | due-trials |
Ongoing | 2021-001123-40 | 18F-fluciclovine PET/CT and 18F-DCFPyL PET/CT in patients with biochemical recurrence of disease after radical prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial 18... | not-yet-due | |
Ongoing | 2021-003850-21 | Precision psychiatry: Anti-inflammatory medication in Immuno-metabolic depression Precieze psychiatrie: Anti-inflammatoire medicatie bij immune-metabole depressie | not-yet-due | |
Ongoing | 2021-004791-34 | Efficacy, safety and cost-effectiveness of B cell tailored ocrelizumab versus standard ocrelizumab in relapsing remitting multiple sclerosis: a randomized controlled trial | not-yet-due | |
Completed, report not yet due | 2021-005344-30 | TETRA-pilot: Testosterone in transgender women after vaginoplasty: a dose-finding and feasibility pilot study | 2023-08-23 | not-yet-due |
Ongoing | 2021-005474-25 | DiEtary Sodium Intake effects on ertugliflozin-induced changes in GFR, reNal oxygenation and systemic hemodynamics: the DESIGN study, a randomized, placebo-controlled, cross-over study with ertugliflo... | not-yet-due | |
Ongoing | 2021-006108-34 | Trial Examining Methods for Antidepressant Discontinuation Methoden om antidepressiva te stoppen vergeleken. De TEMPO-studie | not-yet-due | |
Ongoing | 2022-002214-17 | COLLISION RELAPSE trial - Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvantsystemic therapy - a phase III prospective randomized controlled trial COLLISION RELAPSE trial... | not-yet-due | |
Ongoing | 2022-002400-20 | Feasibility of empagliflozin as treatment for idiopathic pulmonary arterial hypertension Haalbaarheidsstudie van empagliflozine als behandeling voor idiopathische pulmonale arteriële hypertensie | not-yet-due | |
Ongoing | 2022-002481-32 | Imaging inflammation in Alzheimer's Disease | not-yet-due |